DeLorean Artificial Intelligence

About:

DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI).

Website: https://deloreanai.com/

Twitter/X: deloreanai

Top Investors: Sopris Capital Associates, Pinta Capital Partners

Description:

DeLorean AI is an artificial intelligence product company with products in healthcare (Medical AI) & sales (Sales AI). Medical AI predicts disease onset, transition and next best action (NBA) to slow the progress of disease and get the patient better. Medical AI is the first AI in the world to be biologically validated as well as the first AI to be applied at scale to focus on patient health. Currently, Medical AI has processed 45M patients and touches ~50% of the renal patients in the USA. Medical AI on average saves $100PMPM. Sales AI has been developed for B2B and B2C and is deployed at Fortune 500 companies. Our business model is AI as a Service.

Total Funding Amount:

$10.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palm Beach, Florida, United States

Founded Date:

2019-01-01

Contact Email:

fluxcapacitor(AT)deloreanai.com

Founders:

Severence MacLaughlin

Number of Employees:

11-50

Last Funding Date:

2023-09-11

IPO Status:

Private

© 2024 MyAiNote.com